Back to Search
Start Over
Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
- Source :
-
Oral Oncology . Jul2022, Vol. 130, pN.PAG-N.PAG. 1p. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 13688375
- Volume :
- 130
- Database :
- Academic Search Index
- Journal :
- Oral Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 157302353
- Full Text :
- https://doi.org/10.1016/j.oraloncology.2022.105905